Home » Authors » Donna Young

Articles by Donna Young

Adnexus Nixes IPO Route, Opts For $430M BMS Exit

Sep. 25, 2007

Pharmaceutical giant Bristol-Myers Squibb Co. is acquiring Waltham-Mass.-based Adnexus Therapeutics Inc. for $430 million in an all-cash deal, the firms said Monday. (BioWorld Today)

Adnexus Nixes IPO Route, Opts For $430M BMS Exit

Sep. 25, 2007

Pharmaceutical giant Bristol-Myers Squibb Co. is acquiring Waltham-Mass.-based Adnexus Therapeutics Inc. for $430 million in an all-cash deal, the firms said Monday. (BioWorld Today)

Senate Joins House In Passing FDA Bill That Renews PDUFA

Sep. 24, 2007

Roche Places Hold On Trial Of Hepatitis Drug From Maxygen

Sep. 24, 2007

Roche Places Hold On Trial Of Hepatitis Drug From Maxygen

Sep. 24, 2007

Senate Joins House In Passing FDA Bill That Renews PDUFA

Sep. 24, 2007

House Passes Long-Awaited Legislation On FDA Reform

Sep. 21, 2007

House Passes Long-Awaited Legislation On FDA Reform

Sep. 21, 2007

Companies, Others Should Plan: Personalized Medicine Coming

Sep. 20, 2007

Companies, Others Should Plan: Personalized Medicine Coming

Sep. 20, 2007

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...